GIP/GLP-1 dual agonist, 39-residue peptide, 4,813.45 g/mol. C20 diacid side chain at Lys20.
GLP-1 receptor agonist, 31-residue peptide, 4,113.58 g/mol. C18 diacid side chain at Lys26.
Triple GIP/GLP-1/glucagon agonist, 10 mg research vial. Batch COA with identity and purity.
Triple GIP/GLP-1/glucagon agonist, 20 mg research vial. Concentrated format for assay work.
Triple GIP/GLP-1/glucagon agonist, 30 mg research vial. Bulk supply for distributors.
Triple GIP/GLP-1/glucagon agonist, 40 mg research vial. Highest-strength format we carry.
All material in this class is supplied as research use only — it is not a finished dosage form and carries no therapeutic, clinical or dosing claim. Buyers are responsible for their own regulatory and patent position in the destination jurisdiction. Cagrilintide sits in the same research class.
B2B trade only — request a quote
All peptides are research-grade, for in-vitro use only, and supplied against a valid drug licence. Tell us your sequence, quantity and destination and the trade desk will respond within one business day.